title: When to leave a stone unturned ...
authors.affiliation: Digestive Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Building 10, Room 9C-101, Bethesda, MD 20892-1804, USA. vonroe@yahoo.com
authors.forename: Erik C
authors.initials: EC
authors.lastname: von Rosenvinge
authors.forename: Christopher
authors.initials: C
authors.lastname: Koh
authors.forename: Steven M
authors.initials: SM
authors.lastname: Holland
authors.forename: Theo
authors.initials: T
authors.lastname: Heller
mesh_terms: D000293:Adolescent; D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D002443:Ceftriaxone / Q000009:adverse effects*; D041761:Cholecystolithiasis / Q000139:chemically induced* / Q000000981:diagnostic imaging; D006801:Humans; D008199:Lymphadenitis / Q000000981:diagnostic imaging / Q000188:drug therapy*; D008297:Male; D014057:Tomography, X-Ray Computed
chemical_list: D000900:Anti-Bacterial Agents; D002443:Ceftriaxone